Pinkerton Retirement Specialists’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.76M | Sell |
34,253
-35,028
| -51% | -$6.59M | 0.58% | 22 |
|
|
2026
Q1 | $6.37M | Buy |
69,281
+34,264
| +98% | +$6.61M | 0.58% | 31 |
|
|
2025
Q4 | $6.44M | Sell |
35,017
-384
| -1% | -$67.3K | 0.66% | 32 |
|
|
2025
Q3 | $5.43M | Buy |
35,401
+2,478
| +8% | +$375K | 0.58% | 40 |
|
|
2025
Q2 | $4.6M | Buy |
32,923
+940
| +3% | +$132K | 0.55% | 43 |
|
|
2025
Q1 | $4.7M | Buy |
31,983
+268
| +0.8% | +$38.8K | 0.61% | 39 |
|
|
2024
Q4 | $4.16M | Sell |
31,715
-653
| -2% | -$91.4K | 0.6% | 50 |
|
|
2024
Q3 | $5.04M | Buy |
32,368
+3,260
| +11% | +$526K | 0.73% | 35 |
|
|
2024
Q2 | $4.54M | Buy |
29,108
+1,314
| +5% | +$198K | 0.7% | 34 |
|
|
2024
Q1 | $3.77M | Buy |
27,794
+8,011
| +40% | +$1.06M | 0.61% | 46 |
|
|
2023
Q4 | $2.66M | Sell |
19,783
-963
| -5% | -$125K | 0.51% | 45 |
|
|
2023
Q3 | $2.81M | Sell |
20,746
-11
| -0.1% | -$1.5K | 0.61% | 36 |
|
|
2023
Q2 | $2.97M | Buy |
20,757
+228
| +1% | +$33.5K | 0.59% | 38 |
|
|
2023
Q1 | $2.85M | Buy |
20,529
+385
| +2% | +$51.8K | 0.53% | 42 |
|
|
2022
Q4 | $2.73M | Buy |
20,144
+1,613
| +9% | +$202K | 0.59% | 32 |
|
|
2022
Q3 | $2.03M | Sell |
18,531
-1,261
| -6% | -$160K | 0.78% | 43 |
|
|
2022
Q2 | $2.62M | Sell |
19,792
-2,988
| -13% | -$392K | 0.79% | 32 |
|
|
2022
Q1 | $3.02M | Buy |
22,780
+2,274
| +11% | +$273K | 0.67% | 43 |
|
|
2021
Q4 | $2.39M | Buy |
20,506
+848
| +4% | +$99.8K | 0.42% | 59 |
|
|
2021
Q3 | $2.36M | Buy |
19,658
+747
| +4% | +$87K | 0.46% | 62 |
|
|
2021
Q2 | $2.27M | Buy |
18,911
+560
| +3% | +$61.4K | 0.44% | 63 |
|
|
2021
Q1 | $1.82M | Buy |
18,351
+1,298
| +8% | +$130K | 0.38% | 75 |
|
|
2020
Q4 | $1.71M | Sell |
17,053
-715
| -4% | -$75.7K | 0.41% | 73 |
|
|
2020
Q3 | $1.95M | Sell |
17,768
-1,047
| -6% | -$116K | 0.53% | 50 |
|
|
2020
Q2 | $1.99M | Buy |
18,815
+5,171
| +38% | +$534K | 0.63% | 40 |
|
|
2020
Q1 | $1.22M | Sell |
13,644
-25,931
| -66% | -$2.44M | 0.85% | 21 |
|
|
2019
Q4 | $3.95M | Buy |
39,575
+642
| +2% | +$60.4K | 1.26% | 18 |
|
|
2019
Q3 | $3.47M | Buy |
38,933
+1,129
| +3% | +$97.9K | 1.19% | 18 |
|
|
2019
Q2 | $3.12M | Buy |
37,804
+1,281
| +4% | +$100K | 1.09% | 21 |
|
|
2019
Q1 | $2.95M | Buy |
36,523
+3,175
| +10% | +$250K | 1.08% | 22 |
|
|
2018
Q4 | $2.53M | Buy |
33,348
+268
| +0.8% | +$20.9K | 1.28% | 18 |
|
|
2018
Q3 | $2.62M | Sell |
33,080
-83
| -0.3% | -$6.28K | 1.05% | 24 |
|
|
2018
Q2 | $2.33M | Sell |
33,163
-3,612
| -10% | -$260K | 1% | 31 |
|
|
2018
Q1 | $2.57M | Sell |
36,775
-3,892
| -10% | -$270K | 1.09% | 24 |
|
|
2017
Q4 | $2.88M | Buy |
40,667
+877
| +2% | +$59.1K | 1.27% | 18 |
|
|
2017
Q3 | $2.73M | Buy |
39,790
+1,068
| +3% | +$67.5K | 1.34% | 20 |
|
|
2017
Q2 | $2.64M | Sell |
38,722
-655
| -2% | -$42.8K | 1.52% | 16 |
|
|
2017
Q1 | $2.45M | Sell |
39,377
-3,417
| -8% | -$199K | 1.37% | 24 |
|
|
2016
Q4 | $2.34M | Buy |
42,794
+992
| +2% | +$56.3K | 1.09% | 26 |
|
|
2016
Q3 | $3.11M | Buy |
41,802
+874
| +2% | +$57.1K | 1.31% | 15 |
|
|
2016
Q2 | $2.47M | Buy |
40,928
+1,127
| +3% | +$65.5K | 1.24% | 20 |
|
|
2016
Q1 | $2.24M | Buy |
39,801
+9,254
| +30% | +$556K | 1.43% | 30 |
|
|
2015
Q4 | $2.07M | Buy |
30,547
+766
| +3% | +$50.2K | 1.34% | 20 |
|
|
2015
Q3 | $1.9M | Sell |
29,781
-1,019
| -3% | -$67K | 2.69% | 18 |
|
|
2015
Q2 | $1.96M | Buy |
30,800
+1,977
| +7% | +$135K | 1.21% | 25 |
|
|
2015
Q1 | $1.97M | Sell |
28,823
-27,906
| -49% | -$1.94M | 1.31% | 22 |
|
|
2014
Q4 | $1.91M | Buy |
+56,729
| New | +$4.06M | 1.46% | 21 |
|
Other funds holding AZN
RG
CDDEC
BTCPP
AAMU
ISS
AIM
Pinkerton Retirement Specialists's AZN Position: Q2 2026 in Review
Pinkerton Retirement Specialists reduced its AstraZeneca (AZN) stake by 51% in Q2 2026, selling an estimated $6.59M and leaving 34,253 shares worth $6.76M. The position accounts for 0.58% of the portfolio, ranked #22.
Pinkerton Retirement Specialists first reported a position in AZN in Q4 2014 and has held it in 47 quarters since. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Pinkerton Retirement Specialists held 34,253 shares of AstraZeneca worth $6.76M as of Q2 2026.
- Pinkerton Retirement Specialists sold 35,028 AstraZeneca shares in Q2 2026, an estimated $6.59M.
- AstraZeneca made up 0.58% of Pinkerton Retirement Specialists's portfolio in Q2 2026, its #22 holding.
- Pinkerton Retirement Specialists first reported a position in AstraZeneca in Q4 2014 and has held it in 47 quarters since.
- 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Pinkerton Retirement Specialists's 13F filing for Q2 2026, filed 30 Jul 2026.